Lamivudine for children with chronic hepatitis B [6]

American Journal of Gastroenterology

Volumn 95, Issue 10, 2000, Pages 2989-2990

  Koçak, Nurten ^a   Özen, Hasan ^a   Saltik, Inci Nur ^a   Gürakan, Figen ^a   Yüce, Aysel ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; VIRUS DNA;

ADOLESCENT; CHILD; FEMALE; HEPATITIS B; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0033784389     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)02012-8     Document Type: Letter

References (6)

1. Recombinant interferon alpha 2a with or without steroid pretreatment in children with chronic hepatitis B
2. Comparison of standard and high dosage recombinant interferon alpha 2b for treatment of children with chronic hepatitis B infection
3. Lamivudine as initial treatment for chronic hepatitis B in the United States
4. Lamivudine treatment for children with interferon refractory chronic hepatitis B
5. Role of lamivudine in the treatment of chronic hepatitis B virus infection
6. Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: A randomised trial